These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16153869)

  • 21. Assessment of the correlation of platelet morphology with in vivo recovery and survival.
    Mintz PD; Anderson G; Avery N; Clark P; Bonner RF
    Transfusion; 2005 Aug; 45(2 Suppl):72S-80S. PubMed ID: 16086792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet function in variable platelet split products intended for neonatal transfusion.
    Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage.
    Hirayama J; Azuma H; Fujihara M; Homma C; Yamamoto S; Ikeda H
    Transfusion; 2007 Jun; 47(6):960-5. PubMed ID: 17524083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality assessment of platelet concentrate prepared at a tertiary centre in Nigeria.
    Fasola FA; Okunade MA; Abjah UM
    Afr J Med Med Sci; 2002 Dec; 31(4):337-9. PubMed ID: 15027775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
    Rebibo D; Simonet M; Hauser L
    Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between in vitro properties of washed platelet concentrates suspended in M-sol and those in BRS-A, both of which were prepared with an automated cell processor.
    Iwama A; Hirayama J; Nogawa M; Shiba M; Satake M; Takamoto S; Tadokoro K
    Transfus Apher Sci; 2017 Apr; 56(2):241-244. PubMed ID: 28237840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in platelet transfusion].
    Kummer H
    Ther Umsch; 1973 Nov; 30(11):797-801. PubMed ID: 4585652
    [No Abstract]   [Full Text] [Related]  

  • 32. Imported platelets demonstrate decreased pH and glucose by reagent strip testing when compared to locally derived platelets.
    Clark P; Parsons TM; Boyd JC; Dewey P; Mintz PD
    Ann Clin Lab Sci; 2006; 36(4):443-6. PubMed ID: 17127732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of L-carnitine during storage of buffy-coat platelet concentrates in an additive solution.
    Aleil B; Isola H; Cazenave JP
    Vox Sang; 2005 Jul; 89(1):59-60. PubMed ID: 15938742
    [No Abstract]   [Full Text] [Related]  

  • 35. Past and future approaches to assess the quality of platelets for transfusion.
    Maurer-Spurej E; Chipperfield K
    Transfus Med Rev; 2007 Oct; 21(4):295-306. PubMed ID: 17900491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability.
    Ezuki S; Kanno T; Ohto H; Herschel L; Ito T; Kawabata K; Seino O; Ikeda K; Nollet KE
    Vox Sang; 2008 May; 94(4):292-8. PubMed ID: 18331381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of IgA-deficient platelets.
    Sloand EM; Fox SM; Banks SM; Klein HG
    Transfusion; 1990 May; 30(4):322-6. PubMed ID: 2349632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in transfusion for storage of platelets].
    Cazenave JP; Isola H; Gachet C; Aleil B
    Transfus Clin Biol; 2005 Jun; 12(2):226-9. PubMed ID: 15950893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells.
    Wahlström O; Linder C; Kalén A; Magnusson P
    Platelets; 2007 Mar; 18(2):113-8. PubMed ID: 17365859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.